Fractal Analysis of Retinal Microvasculature and Its Association with Cardiovascular Outcomes: A Systematic Review and Meta-Analysis - Scorecard - MDSpire
Coming Soon: Introducing MDSpire News. Learn more
Conexiant’s news site is now MDSpire News. Learn more

Fractal Analysis of Retinal Microvasculature and Its Association with Cardiovascular Outcomes: A Systematic Review and Meta-Analysis

  • By

  • Yihao Lian

  • Guixin Li

  • Haoyu Liu

  • Qing Zhang

  • November 26, 2025

Share

Clinical Scorecard: Fractal Analysis of Retinal Microvasculature and Its Association with Cardiovascular Outcomes: A Systematic Review and Meta-Analysis

At a Glance

CategoryDetail
Condition
Key Mechanisms
Target PopulationIndividuals at risk for cardiovascular diseases, including stroke, coronary heart disease, hypertension, and those with existing CVD.
Care Setting

Key Highlights

  • Fractal dimension (FD) is associated with various CVD outcomes.
  • Retinal microvasculature may serve as a non-invasive biomarker for CVD.
  • Inconsistencies exist in the relationship between FD and specific CVD types; further research is needed.
  • FD analysis can differentiate between retinal arterioles and venules in relation to CVD risk.
  • Systematic review and meta-analysis conducted to evaluate FD's role in CVD risk stratification.

Guideline-Based Recommendations

Diagnosis

    Management

      Monitoring & Follow-up

      • R
      • e
      • g
      • u
      • l
      • a
      • r
      • m
      • o
      • n
      • i
      • t
      • o
      • r
      • i
      • n
      • g
      • o
      • f
      • r
      • e
      • t
      • i
      • n
      • a
      • l
      • F
      • D
      • m
      • a
      • y
      • p
      • r
      • o
      • v
      • i
      • d
      • e
      • i
      • n
      • s
      • i
      • g
      • h
      • t
      • s
      • i
      • n
      • t
      • o
      • C
      • V
      • D
      • p
      • r
      • o
      • g
      • r
      • e
      • s
      • s
      • i
      • o
      • n
      • ;
      • c
      • o
      • n
      • s
      • i
      • d
      • e
      • r
      • a
      • s
      • s
      • e
      • s
      • s
      • m
      • e
      • n
      • t
      • s
      • e
      • v
      • e
      • r
      • y
      • 6
      • -
      • 1
      • 2
      • m
      • o
      • n
      • t
      • h
      • s
      • .

      Risks

        Patient & Prescribing Data

        Incorporating retinal FD analysis into routine evaluations may enhance risk stratification; be aware of potential limitations.

        Clinical Best Practices

        • Adopt standardized methods for calculating FD in retinal images.
        • Ensure comprehensive patient history and clinical examination to corroborate CVD diagnosis.
        • Utilize both cohort and cross-sectional studies for a holistic understanding of FD and CVD relationships.
        • Incorporate patient demographics in FD analysis for better risk assessment.

        Related Resources & Content

        Original Source(s)

        Fractal Analysis of Retinal Microvasculature and Its Association with Cardiovascular Outcomes: A Systematic Review and Meta-Analysis

        • by Yihao Lian, Guixin Li, Haoyu Liu, Qing Zhang

        • November 26, 2025

        Related Content

        AI Falls Short on Differential Dx

        New PrIME-LLM benchmark shows strong diagnostic accuracy but persistent gaps in clinical reasoning across 21 large language models

        Diabetes Risk Scores: Beyond Glucose

        Multi-ancestry polygenic models identify high-risk patients traditional screening may miss.

        Retinal Age Model Tied to Disease Risk

        Fundus-based tool estimates biologic aging but shows modest gains over prior models